Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment

American Journal of Epidemiology

Volumn 182, Issue 1, 2015, Pages 17-25

  McGrath, Leah J ^a   Ellis, Alan R ^a   Brookhart, M Alan ^a  

^a NONE

Author keywords

bias (epidemiology); confounding factors (epidemiology); influenza vaccines; renal dialysis

Indexed keywords

INFLUENZA VACCINE; RECOMBINANT ERYTHROPOIETIN; VITAMIN D;

BASELINE CONDITIONS; DISEASE CONTROL; EPIDEMIOLOGY; HEALTH STATUS; INFLUENZA; MORTALITY; TIME DEPENDENT BEHAVIOR; VACCINE;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; FRAIL ELDERLY; HEALTH STATUS; HEMODIALYSIS PATIENT; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; SAMPLE SIZE; SEASONAL INFLUENZA; CHRONIC KIDNEY FAILURE; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL;

UNITED STATES;

AGED; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HEALTH STATUS; HUMANS; INFLUENZA VACCINES; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS;

EID: 84936761499     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu485     Document Type: Article

References (41)

1. Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med. 2011;26(5):546-550.
2. Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol. 2007;166(3):348-354.
3. Dormuth CR, Patrick AR, Shrank WH, et al. Statin adherence and risk of accidents: a cautionary tale. Circulation. 2009; 119(15):2051-2057.
4. RayWA, Daugherty JR, Griffin MR. Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj Prev. 2002; 8(4):276-279.
5. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006;35(2): 345-352.
6. Kurth T, Walker AM, Glynn RJ, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol. 2006;163(3):262-270.
7. Lunt M, Solomon D, Rothman K, et al. Different methods of balancing covariates leading to different effect estimates in the presence of effect modification. Am J Epidemiol. 2009; 169(7):909-917.
8. Stürmer T, Rothman KJ, Avorn J, et al. Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution-A simulation study. Am J Epidemiol. 2010;172(7):843-854.
9. Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357(14):1373-1381.
10. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184(6): 665-670.
11. Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med. 2005;165(3):274-280.
12. Fireman B, Lee J, Lewis N, et al. Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol. 2009;170(5):650-656.
13. McGrath LJ, Kshirsagar AV, Cole SR, et al. Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med. 2012;172(7):548-554.
14. Dublin S, JacksonM, Marsh T, et al. New approaches to account for selection bias and confounding by frail status [abstract 427]. Pharmacoepidemiol Drug Saf. 2013;22(suppl 1):1-521.
15. Nelson JC, Jackson ML, Weiss NS, et al. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol. 2009; 62(7):687-694.
16. Update: influenza activity-United States and worldwide, 2005-06 season, and composition of the 2006-07 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2006;55(23): 648-653.
17. Update: influenza activity-United States and worldwide, 2006-07 season, and composition of the 2007-08 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2007;56(31): 789-794.
18. Influenza activity-United States and worldwide, 2007-08 season. MMWR Morb Mortal Wkly Rep. 2008;57(25):692-697.
19. D'Agostino RB, Lee ML, Belanger AJ, et al. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med. 1990;9(12): 1501-1515.
20. Cox DR. Regression models and life tables [with discussion]. J R Stat Soc B. 1972;34:187-220.
21. Hernán MA, Robins JM. Estimating causal effects from epidemiological data. J Epidemiol Community Health. 2006; 60(7):578-586.
22. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol. 2008;168(6): 656-664.
23. Hanley JA, Negassa A, Edwardes MD, et al. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003;157(4):364-375.
24. Jackson LA, Jackson ML, Nelson JC, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337-344.
25. Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine. 2010;28(45):7267-7272.
26. Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-Acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet. 2008;372(9636):398-405.
27. Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7(10):658-666.
28. Eleftheriadis T, Antoniadi G, Liakopoulos V, et al. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007;20(5):440-451.
29. Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008;3(5):1526-1533.
30. Crespo M, Collado S, Mir M, et al. Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol. 2011;6(9):2208-2214.
31. McGrath LJ, Cole SR, Kshirsagar AV, et al. Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailty. Med Care. 2013;51(12):1106-1113.
32. Jackson ML, Nelson JC, Jackson LA. Why do covariates defined by International Classification of Diseases codes fail to remove confounding in pharmacoepidemiologic studies among seniors Pharmacoepidemiol Drug Saf. 2011;20(8): 858-865.
33. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004; 57(2):131-141.
34. Schneeweiss S, Patrick AR, Stürmer T, et al. Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care. 2007;45(10 suppl 2):S131-S142.
35. Glynn RJ, Schneeweiss S, Stürmer T. Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol. 2006;98(3):253-259.
36. Hanley JA, Dendukuri N. Efficient sampling approaches to address confounding in database studies. Stat Methods Med Res. 2009;18(1):81-105.
37. Jackson ML, Yu O, Nelson JC, et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol. 2013; 178(8):1327-1336.
38. Lipsitch M, Tchetgen Tchetgen E, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21(3):383-388.
39. Brookhart MA, Walker AM, Lu Y, et al. Characterizing vaccine-Associated risks using cubic smoothing splines. Am J Epidemiol. 2012;176(10):949-957.
40. Tseng HF, Smith N, Harpaz R, et al. Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease. JAMA. 2011;305(2):160-166.
41. Brookhart MA, Patrick AR, Shrank WH, et al. Validating studies of adherence through the use of control outcomes and exposures [reviewer commentary]. Am J Hypertens. 2010; 23(2):110.